The Safety and Effectiveness of UroLift: LIFT Pivotal Study (LIFT)
Luminal Improvement Following Prostatic Tissue Approximation for the Treatment of Lower Urinary Tract Symptoms
Sponsor: NeoTract, Inc.
A NA clinical study on Benign Prostatic Hyperplasia, this trial is completed. The trial is conducted by NeoTract, Inc. and has accumulated 10 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
10 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jan 2021 — Jul 2024 [monthly]
Completed NA
-
Oct 2018 — Jan 2021 [monthly]
Completed NA
▶ Show 5 earlier versions
-
Jun 2018 — Oct 2018 [monthly]
Completed NA
-
Mar 2018 — Jun 2018 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Aug 2017 — Mar 2018 [monthly]
Active Not Recruiting NA
Phase: PHASE3 → NA
-
Feb 2017 — Aug 2017 [monthly]
Active Not Recruiting PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE3
First recorded
Feb 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- NeoTract, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .